Journal Club 2025

Next HOPA Journal Club

Thursday, December 18, 2025 at 12 p.m. Central Time

Listen to critical evaluations of hematology/oncology pharmacy publications presented by PGY2 Oncology Residents.

Click here to register for December's Journal Club!

Christopher Korfiatis, PharmD

PGY2 Oncology Pharmacy Resident

University of Illinois Hospital, Chicago, IL

Article:

Zongertinib in Previously Treated HER2-Mutant Non-Small-Cell Lung Cancer

Featured Articles

An image of Acute Myeloid Leukemia cells

HOPA News

Late-Breaking HOPA News: The Evolving Landscape of NPM1-Mutated AML

November 24, 2025

Moh'd Mohanad A. Al-Dabet, PhD, AHI(AMT); Katia Al-Sawalha, BSc; and Olivia White, PharmD, BCOP, review revumenib and ziftomenib for NPM-1m disease and highlight key considerations when implementing these two therapies.

Advocacy

What HOPA Members Should Know About the End of the 2025 U.S. Government Shutdown

November 14, 2025

On Wednesday, November 12, Congress passed a continuing resolution to re-open the government after a record 43-day shutdown. Here's what HOPA members should know about the bill and what's happening next.

Advocacy

HOPA Endorses ISOPP & UICC Statement on Ensuring International Cancer Drug Quality and Equity

November 04, 2025

ISOPP and UICC recently released a statement calling for quality and equity of cancer treatments in sub-Saharan Africa. HOPA has joined with oncology and pharmacy organizations worldwide to endorse their statement.